Understanding hypertriglyceridemia in women: clinical impact and management with prescription omega-3-acid ethyl esters

References

• FordESLiCZhaoGHypertriglyceridemia and its pharmacologic treatment among US adultsArch Int Med2009169657257819307519
   PubMedGoogle Scholar
• BlahaMBlumenthalRBrintonEJacobsonTThe importance of non-HDL cholesterol reporting in lipid managementJ Clin Lipidol20082426727321291742
   PubMed Web of Science ®Google Scholar
• CastelliWPEpidemiology of triglycerides: a view from FraminghamAm J Cardiol199270193H9H
   PubMed Web of Science ®Google Scholar
• KnoppRHParamsothyPAtkinsonBDowdyAComprehensive lipid management versus aggressive low-density lipoprotein lowering to reduce cardiovascular riskAm J Cardiol20081018A48B57B
   PubMed Web of Science ®Google Scholar
• Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)Executive summary of the third report of the National Cholesterol Education Program (NCEP)JAMA2001285192486249711368702
   PubMed Web of Science ®Google Scholar
• HendersonJTWeismanCSWomen’s patterns of provider use across the lifespan and satisfaction with primary care coordination and comprehensivenessMed Care200543882683316034297
   PubMed Web of Science ®Google Scholar
• PackardCJDemantTStewartJPApolipoprotein B metabolism and the distribution of VLDL and LDL subfractionsJ Lipid Res20004130531710681415
   PubMed Web of Science ®Google Scholar
• BaysHRationale for prescription omega-3-acid ethyl ester therapy for hypertriglyceridemia: a primer for cliniciansDrugs Today (Barc)200844320524618536782
   PubMed Web of Science ®Google Scholar
• LichtensteinAHThematic review series: patient-oriented research. Dietary fat, carbohydrate, and protein: effects on plasma lipoprotein patternsJ Lipid Res20064781661166716738356
   PubMed Web of Science ®Google Scholar
• RaderDHobbsHChapter 350. Disorders of lipoprotein metabolismFauciABraunwaldEKasperD, eds. Harrison’s Principles of Internal Medicine http://www.accessmedicine.com/content.aspx?aID=2882429. Accessed January 12, 2011.
   Google Scholar
• BrewerHBJrHypertriglyceridemia: changes in the plasma lipoproteins associated with an increased risk of cardiovascular diseaseAm J Cardiol1999839B3F12F
   Web of Science ®Google Scholar
• LangerTStroberWLevyRIThe metabolism of low density lipoprotein in familial type II hyperlipoproteinemiaJ Clin Invest1972516152815364336943
   PubMed Web of Science ®Google Scholar
• CaslakeMJPackardCJPhenotypes, genotypes and response to statin therapyCurr Opin Lipidol200415438739215243210
   PubMed Web of Science ®Google Scholar
• El HarchaouiKvan der SteegWStroesEValue of low-density lipoprotein particle number and size as predictors of coronary artery disease in apparently healthy men and women: the EPIC-Norfolk Prospective Population StudyJ Am Coll Cardiol200749554755317276177
   PubMed Web of Science ®Google Scholar
• DayspringTHigh-density lipoproteins: emerging knowledgeCardiometab Syndr2007215962
   Google Scholar
• GeorgievaAMvan GreevenbroekMMKraussRMSubclasses of low-density lipoprotein and very low-density lipoprotein in familial combined hyperlipidemia: relationship to multiple lipoprotein phenotypeArterioscler Thromb Vasc Biol200424474474914751815
   PubMed Web of Science ®Google Scholar
• GrundySMHypertriglyceridemia, insulin resistance, and the metabolic syndromeAm J Cardiol1999839B25F29F
   PubMed Web of Science ®Google Scholar
• GuerinMLe GoffWLasselTSAtherogenic role of elevated CE transfer from HDL to VLDL(1) and dense LDL in type 2 diabetes: impact of the degree of triglyceridemiaArterioscler Thromb Vasc Biol200121228228811156866
   PubMed Web of Science ®Google Scholar
• GrundySMHypertriglyceridemia, atherogenic dyslipidemia, and the metabolic syndromeAm J Cardiol1998814A18B25B
   Web of Science ®Google Scholar
• TothPPDayspringTDPokrywkaGSDrug therapy for hypertriglyceridemia: fibrates and omega-3 fatty acidsCurr Atheroscler Rep2009111717919080732
   PubMed Web of Science ®Google Scholar
• Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final reportCirculation2002106253143342112485966
   PubMed Web of Science ®Google Scholar
• Lloyd-JonesDMO’DonnellCJD’AgostinoRBApplicability of cholesterol-lowering primary prevention trials to a general population: the Framingham Heart StudyArch Int Med2001161794995411295957
   PubMedGoogle Scholar
• MoscaLJOptimal management of cholesterol levels and the prevention of coronary heart disease in womenAm Fam Phys2002652217226
   Web of Science ®Google Scholar
• American Diabetes AssociationWinning at work: diabetes facts http://www.diabetes.org/communityprograms-and-localevents/waw-diabetes-facts.jsp. Accessed January 2, 2011.
   Google Scholar
• KolovouGDBilianouHGInfluence of aging and menopause on lipids and lipoproteins in womenAngiology200859Suppl 254S57S18515273
   PubMed Web of Science ®Google Scholar
• SolhpourAParkhidehSSarrafzadeganNLevels of lipids and apolipoproteins in three culturesAtherosclerosis2009207120020719766218
   PubMed Web of Science ®Google Scholar
• CarrollMDLacherDASorliePDTrends in serum lipids and lipoproteins of adults, 1960–2002JAMA2005294141773178116219880
   PubMed Web of Science ®Google Scholar
• DerbyCACrawfordSLPasternakRCLipid changes during the menopause transition in relation to age and weight: the Study of Women’s Health Across the NationAm J Epidemiol2009169111352136119357323
   PubMed Web of Science ®Google Scholar
• CarrMThe emergence of the metabolic syndrome with menopauseJ Clin Endocrinol Metab20038862404241112788835
   PubMed Web of Science ®Google Scholar
• SowersMZhengHTomeyKChanges in body composition in women over six years at midlife: ovarian and chronological agingJ Clin Endocrinol Metab200792389590117192296
   PubMed Web of Science ®Google Scholar
• PicheMELapointeAWeisnagelSJRegional body fat distribution and metabolic profile in postmenopausal womenMetab Clin Exp20085781101110718640388
   PubMed Web of Science ®Google Scholar
• TchernofADesmeulesARichardCOvarian hormone status and abdominal visceral adipose tissue metabolismJ Clin Endocrinol Metab20048973425343015240626
   PubMed Web of Science ®Google Scholar
• SarwarNDaneshJEiriksdottirGTriglycerides and the risk of coronary heart disease: 10,158 incident cases among 262,525 participants in 29 Western prospective studiesCirculation2007115445045817190864
   PubMed Web of Science ®Google Scholar
• TankoLBBaggerYZQinGEnlarged waist combined with elevated triglycerides is a strong predictor of accelerated atherogenesis and related cardiovascular mortality in postmenopausal womenCirculation2005111151883189015837940
   PubMed Web of Science ®Google Scholar
• NordestgaardBGBennMSchnohrPTybjaerg-HansenANonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and womenJAMA2007298329930817635890
   PubMed Web of Science ®Google Scholar
• FordESGilesWHDietzWHPrevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination SurveyJAMA2002287335635911790215
   PubMed Web of Science ®Google Scholar
• AssmannGSchulteHFunkeHvon EckardsteinAThe emergence of triglycerides as a significant independent risk factor in coronary artery diseaseEur Heart J199819Suppl MM8M149821011
   PubMedGoogle Scholar
• EwaldNHardtPDKloerHUSevere hypertriglyceridemia and pancreatitis: presentation and managementCurr Opin Lipidol200920649750419770656
   PubMed Web of Science ®Google Scholar
• BrunzellJDDavidsonMFurbergCDLipoprotein management in patients with cardiometabolic risk: consensus statement from the American Diabetes Association and the American College of Cardiology FoundationDiabetes Care200831481182218375431
   PubMed Web of Science ®Google Scholar
• LiuJSemposCTDonahueRPNon-high-density lipoprotein and very-low-density lipoprotein cholesterol and their risk predictive values in coronary heart diseaseAm J Cardiol200698101363136817134630
   PubMed Web of Science ®Google Scholar
• GrundySMCleemanJIMerzCNImplications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelinesCirculation2004110222723915249516
   PubMed Web of Science ®Google Scholar
• MoscaLBankaCLBenjaminEJEvidence-based guidelines for cardiovascular disease prevention in women: 2007 updateCirculation2007115111481150117309915
   PubMedGoogle Scholar
• DayspringTHelmboldAYou have a new job: monitor the lipid profileOBG Management20082012227239
   Google Scholar
• MoscaLMochariHChristianANational study of women’s awareness, preventive action, and barriers to cardiovascular healthCirculation2006113452553416449732
   PubMed Web of Science ®Google Scholar
• CookeCEHammerashWJJrRetrospective review of sex differences in the management of dyslipidemia in coronary heart disease: an analysis of patient data from a Maryland-based health maintenance organizationClin Ther200628459159916750470
   PubMed Web of Science ®Google Scholar
• SteinEASnidermanALaskarzewskiPAssessment of reaching goal in patients with combined hyperlipidemia: low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, or apolipoprotein BAm J Cardiol2005969A36K43K discussion34K35K
   Web of Science ®Google Scholar
• WeingartnerOLutjohannDJiSVascular effects of diet supplementation with plant sterolsJ Am Coll Cardiol200851161553156118420097
   PubMed Web of Science ®Google Scholar
• LichtensteinAHAppelLJBrandsMDiet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition CommitteeCirculation20061141829616785338
   PubMed Web of Science ®Google Scholar
• BantleJPWylie-RosettJAlbrightALNutrition recommendations and interventions for diabetes: a position statement of the American Diabetes AssociationDiabetes Care200831Suppl 1S61S7818165339
   PubMed Web of Science ®Google Scholar
• US Department of Health and Human Services and US Department of AgricultureDietary guidelines for Americans, 20056th edWashington, DCUS Government Printing Office2005
   Google Scholar
• Kris-EthertonPMInnisSAmerican Dietetic Association, Dietitians of Canada. Position of the American Dietetic Association and Dietitians of Canada: dietary fatty acidsJ Am Diet Assoc200710791599161117936958
   PubMedGoogle Scholar
• Kris-EthertonPMHarrisWSAppelLJFish consumption, fish oil, omega-3 fatty acids, and cardiovascular diseaseCirculation2002106212747275712438303
   PubMed Web of Science ®Google Scholar
• JacobsonTARole of n-3 fatty acids in the treatment of hypertriglyceridemia and cariovascular diseaseAm J Clin Nutr20088761981S1990S18541599
   PubMed Web of Science ®Google Scholar
• OhRCBeresfordSALaffertyWEThe fish in secondary prevention of heart disease (FISH) survey: primary care physicians and omega3 fatty acid prescribing behaviorsJ Am Board Fam Med200619545946716951295
   PubMed Web of Science ®Google Scholar
• HarrisWSn-3 fatty acids and serum lipoproteins: human studiesAm J Clin Nutr199765Suppl 51645S1654S9129504
   PubMed Web of Science ®Google Scholar
• DavidsonMHMakiKCPearsonTAResults of the National Cholesterol Education (NCEP) Program Evaluation ProjecT Utilizing Novel E-Technology (NEPTUNE) II survey and implications for treatment under the recent NCEP Writing Group recommendationsAm J Cardiol200596455656316098311
   PubMed Web of Science ®Google Scholar
• DavidsonMHBallantyneCMKerznerBEfficacy and safety of ezetimibe coadministered with statins: randomised, placebo-controlled, blinded experience in 2382 patients with primary hypercholesterolemiaInt J Clin Pract200458874675515372846
   PubMed Web of Science ®Google Scholar
• DavidsonMHSteinEABaysHEEfficacy and tolerability of adding prescription omega-3 fatty acids 4 g/d to simvastatin 40 mg/d in hypertriglyceridemic patients: an 8-week, randomized, double-blind, placebo-controlled studyClin Ther20072971354136717825687
   PubMed Web of Science ®Google Scholar
• LOVAZA [prescribing information]Research Triangle Park, NCGlaxoSmithKline2009
   Google Scholar
• HarrisWSGinsbergHNArunakulNSafety and efficacy of Omacor in severe hypertriglyceridemiaJ Cardiovasc Risk199745–63853919865671
   PubMedGoogle Scholar
• PownallHJBrauchiDKilincCCorrelation of serum triglyceride and its reduction by omega-3 fatty acids with lipid transfer activity and the neutral lipid compositions of high-density and low-density lipoproteinsAtherosclerosis1999143228529710217357
   PubMed Web of Science ®Google Scholar
• BaysHETigheAPSadovskyRDavidsonMHPrescription omega-3 fatty acids and their lipid effects: physiologic mechanisms of action and clinical implicationsExpert Rev Cardiovasc Ther20086339140918327998
   PubMedGoogle Scholar
• GoldbergACSchonfeldGFeldmanEBFenofibrate for the treatment of type IV and V hyperlipoproteinemias: a double-blind, placebo-controlled multicenter US studyClin Ther198911169832655907
   PubMed Web of Science ®Google Scholar
• CalabresiLDonatiDPazzucconiFOmacor in familial combined hyperlipidemia: effects on lipids and low density lipoprotein subclassesAtherosclerosis2000148238739610657575
   PubMed Web of Science ®Google Scholar
• BaysHMakiKMcKenneyJLong-term up to 24 month efficacy and safety of concomitant prescription omega-3-acid ethyl esters and simvastatin in hypertriglyceridemic patientsCurr Med Res Opin201026490791520156032
   PubMed Web of Science ®Google Scholar
• DavidsonMMakiKBaysHEffects of prescription omega-3-acid ethyl esters on lipoprotein particle concentrations, apolipoproteins AI and CIII, and lipoprotein associated phospholipase A2 mass in statin-treated subjects with hypertriglyceridemiaJ Clin Lipidol20093533234021291831
   PubMed Web of Science ®Google Scholar
• GinsbergHNZhangYLHernandez-OnoARegulation of plasma triglycerides in insulin resistance and diabetesArch Med Resear2005363232240
   Web of Science ®Google Scholar
• MakiKCMcKenneyJMReevesMSEffects of adding prescription omega-3 acid ethyl esters to simvastatin (20 mg/day) on lipids and lipoprotein particles in men and women with mixed dyslipidemiaAm J Cardiol2008102442943318678300
   PubMed Web of Science ®Google Scholar
• MakiKLubinBReevesMDicklinMPrescription omega-3 acid ethyl esters plus simvastatin 20 and 80 mg: effects in mixed dyslipidemiaJ Clin Lipidol200931333821291786
   PubMed Web of Science ®Google Scholar
• BaysHMcKenneyJMakiKCPrescription omega-3-acid ethyl esters: effects on non-high-density lipoprotein cholesterol in combined hyperlipidemic patients when co-administered with escalating doses of atorvastatinMayo Clin Proc20108512212820118387
   PubMed Web of Science ®Google Scholar
• ContoisJHMcConnellJPSethiAAApolipoprotein B and Cardiovascular Disease Risk: Position Statement from the AACC Lipoproteins and Vascular Diseases Division Working Group on Best PracticesClinical Chemistry200955340741919168552
   PubMed Web of Science ®Google Scholar